Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24686427 | 1.00 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL15691440 | 1.00 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL19132639 | 1.00 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL16907937 | 1.00 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL22704385 | 1.00 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL22022494 | 0.91 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL14356269 | 0.91 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL13486952 | 0.91 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL15127532 | 0.91 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 | |
| SCHEMBL30976643 | 0.91 | ALDH1A1 (0.77) | ALDH1A1HPGDPOLBGAAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340613-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE | IMMUNESENSOR THERAPEUTICS, INC. | 2022-10-27 | — | — | US | disclosed |
| EP-3692996-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE | Immune Sensor, LLC (US) | 2020-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340613-A1 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE | CGAS, PDE7A, PDE11A | ALDH1A1 3411/4885HPGD 201/4885POLB 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.